AMARILLO – Texas Oncology recently broke ground on a new 50,000-square-foot cancer care center in Amarillo that will significantly expand the capacity of the practice to meet the growing need for cancer care in the Texas Panhandle. Located at 1826 Point West Pkwy., the new comprehensive cancer center will provide medical oncology, hematology, gynecologic oncology, radiation oncology, breast radiology, surgical oncology, and colon and rectal surgery services. Once open, patients and their care teams at the existing Texas Oncology, Texas Oncology Surgical Specialists, and Texas Breast Specialists located at 1000 S. Coulter, Suite 100 in Amarillo, will move to the new facility.
“The new, larger facility will increase access to high-quality cancer care, radiology, surgical procedures, and other services for patients in Amarillo and surrounding communities,” said Steven Paulson, M.D., president and chairman of the board, Texas Oncology. “Texas Oncology is a leader in community-based cancer care, and we believe that patients should be able to get leading-edge cancer care from local expert oncology teams, with the critical support of family and friends nearby.”
In addition to multi-disciplinary cancer care, the new center will be nearly a third larger than the current facility and will offer patients opportunities to participate in innovative clinical trials and cancer research. The facility will also provide educational services, genetic risk evaluation and testing, pharmacy services, and support groups.
“Texas Oncology has deep roots in the Amarillo community, and we’re proud to have served this region for more than 20 years,” said Vance Esler, M.D., executive vice president-managing medical director and regional medical director, Texas Oncology. “Offering a comprehensive array of care and services in this single location means a cancer diagnosis can be effectively addressed with less overall disruption to patients’ lives. As the population of Amarillo grows, but also ages, this modern facility will help ensure that we can meet the increased need for leading- edge cancer care in the region.”
NexCore Group, a healthcare-focused real estate developer, last year purchased 4.85 acres of land to develop the freestanding center, which is expected to open in late spring 2023.